Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Tolerability of N-Acetyl- Cysteine for Treatment of The Early-onset Androgenetic Alopecia in Men

NCT04209803 is registered in ClinicalTrials.gov with Kafrelsheikh University as lead sponsor.

NCT NCT04209803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04209803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Tolerability of N-Acetyl- Cysteine for Treatment of The Early-onset Androgenetic Alopecia in Men
Lead sponsor
Kafrelsheikh University
Phase
Phase 4
Overall status
Completed
Start date
December 1, 2018
Completion date
October 1, 2020
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

androgenetic alopecia